TARS insider trades & Congress trades
Tarsus Pharmaceuticals, Inc.: public insider filings and Congress disclosures, in one place.
Bourse has recorded 14 open-market insider transactions in Tarsus Pharmaceuticals, Inc. (TARS) (0 purchases with code P and 14 sales with code S), the most recent on September 15, 2026.
In the last 90 days: 0 purchases by 0 insiders ($0) and 14 sales by 4 ($5.19M).
Insider transactions
SEC Form 4, open-market purchases (P) and sales (S) only. Awards, option exercises and tax withholding are excluded. “After” shows the stock’s return over the month following the trade, where available.
| Date | Insider | Role | Type | Shares | Price | Value | After 1M |
|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | Link William J Phd | – | Sell | 11,675 | $78.33 | $915K | −0.1% |
| Sep 15, 2026 | Link William J Phd | – | Sell | 759 | $79.00 | $60K | −0.1% |
| Sep 15, 2026 | Link William J Phd | – | Sell | 66 | $80.01 | $5K | −0.1% |
| Sep 4, 2026 | Lin Elizabeth Yeu | Chief Medical Officer | Sell | 5,387 | $85.00 | $458K | −0.1% |
| Sep 4, 2026 | Lin Elizabeth Yeu | Chief Medical Officer | Sell | 5,386 | $90.00 | $485K | −0.1% |
| Sep 4, 2026 | Lin Elizabeth Yeu | Chief Medical Officer | Sell | 1,590 | $85.00 | $135K | −0.1% |
| Sep 4, 2026 | Lin Elizabeth Yeu | Chief Medical Officer | Sell | 1,590 | $90.00 | $143K | −0.1% |
| Sep 4, 2026 | Neervannan Seshadri | Chief Operating Officer | Sell | 4,564 | $85.00 | $388K | −0.1% |
| Sep 4, 2026 | Azamian Bobak R. | President/CEO and Board Chair | Sell | 7,100 | $90.27 | $641K | −0.1% |
| Sep 4, 2026 | Azamian Bobak R. | President/CEO and Board Chair | Sell | 2,900 | $91.27 | $265K | −0.1% |
| Sep 2, 2026 | Azamian Bobak R. | President/CEO and Board Chair | Sell | 10,000 | $80.06 | $801K | −0.1% |
| Sep 2, 2026 | Lin Elizabeth Yeu | Chief Medical Officer | Sell | 5,387 | $80.00 | $431K | −0.1% |
| Sep 2, 2026 | Lin Elizabeth Yeu | Chief Medical Officer | Sell | 1,590 | $80.00 | $127K | −0.1% |
| Sep 1, 2026 | Lin Elizabeth Yeu | Chief Medical Officer | Sell | 4,601 | $73.86 | $340K | −0.1% |
Data as of November 8, 2026. Public filings only. A purchase or sale by a politician or an insider does not by itself imply any wrongdoing.
New to these filings? Read how to read a Form 4, how Congress trades are disclosed and what insider cluster buying means. Sources and limits are on the Methodology page.
See these filings as they land
Bourse collects Congress trades, SEC Form 4 insider filings and 13F fund holdings in one live feed, and flags insider buying clusters automatically. Free to start.
Bourse provides financial data and editorial information, parts of which are generated by AI. This page is for general education only. It is not personalised investment advice or a recommendation to buy or sell any financial instrument. Make your own decisions.